The World Health Organization said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection.
The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what the appropriate actions would be.
The WHO said the vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption of Covaxin supply. It said the suspension is in response to the outcomes of WHO post emergency use listing inspection conducted from March 14 to 22, and the vaccine maker has indicated its commitment to suspend production of Covaxin for export.Bharat Biotech did not immediately respond to a request for comment sent outside business hours.
On Friday, the vaccine manufacturer said it was slowing production of Covaxin, as demand was dropping along with a fall in infections and wider immunisation coverage in the country. The WHO said that the company has "committed to comply by addressing the GMP deficiencies and is developing a corrective and preventive action plan, for submission to the Drugs Controller General of India and WHO".Reporting by Vishal Vivek in Bengaluru; Editing by David GregorioSign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 more likely than vaccines to cause heart problems: CDC studyWhile COVID vaccinations increased cardiac risks in some young men, the virus itself was much more likely to cause heart problems, the Centers for Disease Control found.
Read more »
Dr. Kizzmekia Corbett, who worked on Moderna vaccine, cements her place in historyDr. Kizzmekia Corbett is being celebrated for leading a team at the National Institutes of Health that helped develop Moderna's COVID-19 vaccine.
Read more »
COVID Vaccine in kids less effective against Omicron vs Delta, but ward off severe illness from both: studyThe Pfizer/BioNTech COVID-19 vaccine provided less protection against the Omicron variant than the Delta strain in children but did protect against severe illness from both variants.
Read more »
FDA Authorizes Fourth COVID Doses for Many AmericansAdults over 50 and those 18 and older who are immunocompromised are eligible for fourth doses of either Pfizer or Moderna's COVID-19 vaccines.
Read more »
Pfizer Vaccine Potentially Linked to Hearing LossThe WHO is investigating rare instances of hearing loss and other auditory disturbances associated with COVID-19 vaccinations – primarily the Pfizer-BioNTech shots.
Read more »
COVID tests, vaccines help Walgreens beat expectations on earningsWalgreens surpassed Wall Street expectations in the second quarter thanks to strong demand for COVID-19 tests and vaccines.
Read more »